Nighttime breathing stoppages affect sleep and heart health
Obstructive sleep apnea is a common disorder that occurs when the upper airway narrows or repeatedly becomes blocked during sleep, leading to pauses in breathing or significant reductions for more than 10 seconds. This results in decreased oxygen levels, disrupted sleep, and bodily stress. The obstructive episodes occur more than five times per hour and are accompanied by symptoms such as irregular snoring, choking sensations, frequent awakenings, excessive daytime sleepiness, and morning headaches. The condition is often associated with obesity and anatomical abnormalities; increased fat deposits contribute to narrowing the airway. The most effective treatment is continuous positive airway pressure (CPAP), which markedly reduces the number of obstructive episodes and is typically used in moderate to severe cases. Recent studies have shown that medications containing agonists of the glucagon-like peptide-1 receptor (such as tirzepatide) can help lessen the severity of the condition, especially in obese patients, with success rates of up to 50% after one year of therapy. However, the effectiveness of treatment depends on the underlying cause and often requires a combination of medical and surgical interventions if the patient does not improve. If left untreated, the condition increases the risk of cardiovascular diseases and stroke, emphasizing the importance of early diagnosis and appropriate treatment.
Notice: This Is an AI-Generated Summary
Comments (0)